A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis Ellen LuBing Wei WangHelen Tremlett Current Opinion 17 December 2013 Pages: 89 - 94
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders Erin A. McClureCassandra D. GipsonKevin M. Gray Leading Article 18 January 2014 Pages: 95 - 106
Combined Pharmacotherapies for the Management of Alcoholism: Rationale and Evidence to Date Mary R. LeeLorenzo Leggio Leading Article 05 February 2014 Pages: 107 - 119
Attention-Deficit/Hyperactivity Disorder with Inadequate Response to Stimulants: Approaches to Management Ann C. ChildressFloyd R. Sallee Therapy in Practice 09 January 2014 Pages: 121 - 129
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs Michael S. AbersWayne X. ShanderaJoseph S. Kass Review Article 21 December 2013 Pages: 131 - 145
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis Nicola De StefanoLaura AirasBernd C. Kieseier Review Article 22 January 2014 Pages: 147 - 156
A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe Virginie GardetteMaryse Lapeyre-MestreThe ICTUS Group Original Research Article 10 January 2014 Pages: 157 - 170
Aripiprazole: A Review of Its Use in the Treatment of Manic Episodes in Adolescents with Bipolar I Disorder Kate McKeage Adis Drug Evaluation 08 January 2014 Pages: 171 - 183